BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20349257)

  • 21. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen.
    Winn DM; Wolfe JF; Lindberg DA; Fristoe FH; Kingsland L; Sharp GC
    Arthritis Rheum; 1979 Dec; 22(12):1334-7. PubMed ID: 391237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endothelial response for the presence of chosen antinuclear antibodies, anti-Ro (SS-A) and anti-La (SS-B) and anti-Sm in vasculitis against the background of existing lupus erythematosus].
    Doskocz R; Adamiec R; Kwiatkowska W; Alexewicz P; Doskocz W; Adamiec J
    Pol Arch Med Wewn; 1999 Nov; 102(5):955-60. PubMed ID: 11072529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of serum anti-ribosomal P antibody with clinical and serological disorders in systemic lupus erythematosus: a systematic review and meta-analysis.
    Shi ZR; Cao CX; Tan GZ; Wang L
    Lupus; 2015 May; 24(6):588-96. PubMed ID: 25406488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus.
    Barbacki A; Rached-d'Astous N; Pineau CA; Vinet E; Grenier LP; Kalache F; Fallavollita S; Lukusa L; Bernatsky S
    J Clin Rheumatol; 2022 Mar; 28(2):e488-e490. PubMed ID: 35192594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct antiglobulin (Coombs) test in systemic lupus erythematosus patients.
    Skare T; Picelli L; Dos Santos TAG; Nisihara R
    Clin Rheumatol; 2017 Sep; 36(9):2141-2144. PubMed ID: 28762061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies].
    López-Longo FJ; González Fernández CM; Rodríguez Mahou M; Grau Simó R; Monteagudo Sáez I; Meno García AC; Carreño Pérez L
    Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-ribosomal antibodies in systemic lupus erythematosus].
    Corres González JM; Rodríguez Hernández C; Zea Mendoza AC; Sequí Navarro J; Sanchidrián Fernández I
    Rev Clin Esp; 1995 Jan; 195(1):16-21. PubMed ID: 7878261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
    Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
    Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIGH PREVALENCE OF HYPOTHYROIDISM IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT AN INCREASE IN CIRCULATING ANTI-THYROID ANTIBODIES.
    Domingues SL; Gonçalves FT; Jorge MLMP; Limongi JE; Ranza R; Jorge PT
    Endocr Pract; 2017 Nov; 23(11):1304-1310. PubMed ID: 28816533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Ro antibody and clinical manifestations: lessons from systemic lupus erythematosus in the elderly.
    Leng RX; Qin WZ; Pan HF; Ye DQ
    Clin Rheumatol; 2010 Sep; 29(9):1077. PubMed ID: 20544242
    [No Abstract]   [Full Text] [Related]  

  • 32. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
    Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
    Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
    Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
    Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies.
    Ghirardello A; Doria A; Zampieri S; Gerli R; Rapizzi E; Gambari PF
    Ann Rheum Dis; 2000 Dec; 59(12):975-81. PubMed ID: 11087701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus.
    Szmyrka M; Pokryszko-Dragan A; Słotwiński K; Gruszka E; Korman L; Podemski R; Wiland P
    Adv Clin Exp Med; 2019 Feb; 28(2):185-192. PubMed ID: 29963787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus.
    Vilá LM; Mayor AM; Valentín AH; García-Soberal M; Vilá S
    Lupus; 2000; 9(2):110-5. PubMed ID: 10787007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal antibodies to Ro (SS-A) are associated with both early onset of disease and male sex among children with systemic lupus erythematosus.
    Lehman TJ; Reichlin M; Santner TJ; Silverman E; Petty RE; Spencer CH; Harley JB
    Arthritis Rheum; 1989 Nov; 32(11):1414-20. PubMed ID: 2818658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
    Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
    Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.